The natural compounds atraric acid and N-butylbenzene-sulfonamide as antagonists of the human androgen receptor and inhibitors of prostate cancer cell growth
Authors:
- Aria BaniahmadABAria Baniahmad
- 1 January 2011
- journal article
- review article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 332 (1-2) , 1-8
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Pygeum africanum extract inhibits proliferation of human cultured prostatic fibroblasts and myofibroblastsBJU International, 2006
- Nuclear hormone receptor co-repressorsThe Journal of Steroid Biochemistry and Molecular Biology, 2005
- IS THERE A SCIENTIFIC BASIS FOR THE THERAPEUTIC EFFECTS OF SERENOA REPENS IN BENIGN PROSTATIC HYPERPLASIA? MECHANISMS OF ACTIONJournal of Urology, 2004
- Androgen receptor as a target in androgen-independent prostate cancerUrology, 2002
- Eremophilanolides and other constituents from the Argentine liverwort Frullania brasiliensisPhytochemistry, 2002
- Prostate cancer schemes for androgen escapeNature Medicine, 2000
- Mechanisms of androgen receptor activation and functionThe Journal of Steroid Biochemistry and Molecular Biology, 1999
- Atraric acid, a marker for epiphytic lichens in the wood used in cooperage: Identification and quantification by GC/MS/(MS)Analusis, 1999
- Efficacy and Acceptability of Tadenan®(Pygeum africanum Extract) in the Treatment of Benign Prostatic Hyperplasia (BPH): A Multicentre Trial in Central EuropeCurrent Medical Research and Opinion, 1998
- Pygeum africanum extract for the treatment of patients with benign prostatic hyperplasia: A review of 25 years of published experienceCurrent Therapeutic Research, 1995